Rhia Ventures
Elizabeth Bailey has over 15 years of experience in venture capital and supporting early-stage technology companies. She was a Partner at one of the first impact investment funds (Commons Capital LP), where she managed healthcare and education portfolios, which included: Claros Diagnostics (acquired by OPKO), CodeRyte (acquired by 3M), Combinent Biomedical Systems, HistoRx (acquired by Genoptix), Medical Metrx Solutions (acquired by AIG), TelaDoc Medical Services (IPO: TDOC), Valeo Medical, and Apex Learning (acquired by Education Growth Partners). Most recently, Elizabeth served as the Founding Director of the Consortium for Affordable Medical Technologies (CAMTech) at Massachusetts General Hospital, where she built a global program to accelerate medtech innovation and catalyze new health startups. Throughout her career, Elizabeth has been a passionate advocate of the power of business – from startups to multinationals – to drive social change. Elizabeth earned a Master in Public Policy from Harvard University’s Kennedy School of Government and a BA from Brown University.
This person is not in any offices
Rhia Ventures
Rhia Ventures aims to create a vibrant U.S. market for sexual, reproductive, and maternal health that produces equitable outcomes for all. This $50B+ market has perpetuated unjust outcomes for women of color, low-income women, and others directly affected by systemic inequities, preventing them from taking true control of their health. Rhia Ventures seeks to transform this market by empowering all women with access and affordability through our field building, direct investment, corporate engagement, and narrative change work. By exchanging knowledge with our community of entrepreneurs, activists, innovators, and investors and providing technical support and capital together, we can build a vibrant and more equitable market that meets the needs of all women.